Skip to main content
. 2016 May 24;12(6):e697–e709. doi: 10.1200/JOP.2015.009803

Table 2.

Multivariable Logistic Regression Analyses With Multiple Imputation

Variable RS-Eligible Patients (n = 2,418) RS-Receipt Patients (n = 377)
Received RS Chemotherapy Chemotherapy
OR 95% CI P OR 95% CI P OR 95% CI P
Health care system .02 .38 .11
 University Ref Ref Ref Ref Ref Ref
 Community 1.14 0.86 to 1.51 .36 0.86 0.66 to 1.11 .26 1.19 0.59 to 2.42 .62
 Dual 1.73 1.18 to 2.55 .01 1.05 0.71 to 1.54 .82 2.47 1.01 to 6.04 .05
RS receipt .11
 Not received Ref Ref
 Received 0.78 0.58 to 1.05 .11
RS < .001
 Low Ref Ref
 Intermediate 3.66 1.94 to 6.91 < .001
 High 49.39 14.06 to 173.46 < .001
Age at diagnosis, years < .001 < .001 < .001
 < 40 0.42 0.23 to 0.74 .0031 4.69 2.89 to 7.62 < .001 13.01 2.78 to 60.77 .001
 40-49 1.13 0.85 to 1.49 .41 2.83 2.14 to 3.73 < .001 5.70 2.87 to 11.30 < .001
 50-64 Ref Ref Ref Ref Ref Ref
 ≥ 65 0.27 0.17 to 0.43 < .001 0.19 0.13 to 0.29 < .001 0.18 0.03 to 1.08 .06
Year of diagnosis < .001 .12 .03
 2005-2007 Ref Ref Ref Ref Ref Ref
 2008-2009 2.76 2.00 to 3.82 < .001 0.80 0.60 to 1.06 .12 2.10 0.89 to 4.98 .09
 2010-2011 3.68 2.72 to 4.98 < .001 0.77 0.59 to 1.00 .05 0.86 0.38 to 1.95 .71
Race .62 .03 .5
 Non-Hispanic white Ref Ref Ref Ref Ref Ref
 Hispanic 0.94 0.55 to 1.62 .83 1.30 0.79 to 2.13 .3 0.63 0.15 to 2.61 .52
  Non-Hispanic black 0.44 0.12 1.53 .19 3.08 1.26 to 7.55 .01 1.90 0.11 to 32.21 .66
  Non-Hispanic Asian/Pacific Islander 0.96 0.70 to 1.31 .79 1.29 0.96 to 1.72 .09 0.60 0.28 to 1.27 .18
Neighborhood SES statewide quintile .51 .41 .57
 1 Ref Ref Ref Ref Ref Ref
 2 0.81 0.32 to 2.04 .65 1.79 0.72 to 4.47 .21 1.76 0.17 to 18.00 .63
 3 0.72 0.32 to 1.64 .43 1.12 0.49 to 2.57 .79 0.87 0.11 to 7.04 .89
 4 0.67 0.30 to 1.47 .31 1.30 0.58 to 2.95 .52 2.24 0.30 to 16.92 .43
 5 0.87 0.40 to 1.89 .73 1.11 0.51 to 2.44 .79 1.24 0.19 to 8.06 .82
Insurance .4 .19 .17
 Private Ref Ref Ref Ref Ref Ref
 Medicare 0.85 0.51 to 1.40 .51 0.67 0.44 to 1.03 .07 3.30 0.49 to 22.26 .22
 Other 0.66 0.34 to 1.27 .21 0.87 0.51 to 1.48 .6 3.22 0.71 to 14.56 .13
Stage .42 < .001 .01
 I Ref Ref Ref Ref Ref Ref
 II 0.88 0.66 to 1.19 .42 3.62 2.73 to 4.79 < .001 2.74 1.34 to 5.62 .01
No. of involved lymph nodes < .001 < .001 .21
 0 Ref Ref Ref Ref Ref Ref
 1-2 0.19 0.12 to 0.29 < .001 4.32 3.12 to 5.97 < .001 1.96 0.68 to 5.61 .21
Grade .007 < .001 .01
 1 Ref Ref Ref Ref Ref Ref
 2 1.21 0.92 to 1.59 .17 3.12 2.37 to 4.11 < .001 2.70 1.33 to 5.51 .01
 3 0.67 0.44 to 1.01 .06 10.85 7.44 to 15.82 < .001 4.53 1.58 to 12.94 .005
Histology .22 .06 .02
 Ductal Ref Ref Ref Ref Ref Ref
 Lobular 1.39 0.96 to 2.02 .08 0.75 0.51 to 1.11 .15 0.34 0.11 to 0.98 .05
 Other 1.06 0.75 to 1.52 .73 0.69 0.49 to 0.98 .04 0.35 0.13 to 0.90 .03
Laterality .79 .52
 Unilateral Ref Ref Ref Ref *
 Bilateral 1.09 0.56 to 2.13 .79 0.81 0.42 to 1.55 .52

NOTE. Logistic regression models were fit to multiply-imputed data by using five imputations. Coefficient P values and variable P values (in bold) were calculated by using Wald’s z test.

Abbreviations: OR, odds ratio; Ref, reference; RS, recurrence score; SES, socioeconomic status.

*

Categories were collapsed because there were few observations.